Cunninghamella bertholletiae infection in children: review and report of 2 cases with disseminated infection.

J Pediatr Hematol Oncol

*Pediatric Hematology-Oncology Unit †Pediatric Intensive Care Unit §Hematopoietic Transplant Unit, Niño Jesús Children's Hospital ‡Mycology Reference Laboratory, National Centre of Microbiology Carlos III, Madrid, Spain.

Published: March 2014

Mucormycosis is an emerging fungal infection affecting mainly immunosuppressed hosts. Cunninghamella bertholletiae causes the highest mortality among all mucormycetes. Infection by C. bertholletiae has rarely been reported in children. We present 2 children with acute leukemia and disseminated infection by C. bertholletiae, and review the relevant literature.

Download full-text PDF

Source
http://dx.doi.org/10.1097/MPH.0b013e31829eec5aDOI Listing

Publication Analysis

Top Keywords

cunninghamella bertholletiae
8
disseminated infection
8
infection bertholletiae
8
infection
5
bertholletiae infection
4
infection children
4
children review
4
review report
4
report cases
4
cases disseminated
4

Similar Publications

Mucormycosis caused by is a rare opportunistic infection in patients with hematological malignancies (HM), with high mortality rates. Herein, we first report a case of pulmonary mucormycosis (PM) with in a 25-year-old male recently diagnosed with T-lymphoblastic lymphoma (T-LBL). The diagnosis was established through chest computed tomography (CT), metagenomic next-generation sequencing (mNGS) of blood and bronchoalveolar lavage fluid (BALF), as well as histopathological examination.

View Article and Find Full Text PDF

Mucormycosis is an aggressive, angioinvasive infection associated with high morbidity and mortality. The disease remains difficult to treat, with limited available antifungal drugs. Consequently, there is an urgent need to develop alternate therapeutics against mucormycosis.

View Article and Find Full Text PDF

Human Vγ9Vδ2 T cells exhibit antifungal activity against and other filamentous fungi.

Microbiol Spectr

April 2024

Department of Respiratory Medicine, Graduate School of Biomedical Sciences, Nagasaki University, Nagasaki, Japan.

Article Synopsis
  • Invasive aspergillosis (IA) and mucormycosis are severe infections predominantly affecting immunocompromised individuals, and drug-resistant strains present a significant clinical challenge.* -
  • This research explores the potential of Vγ9Vδ2 T cells, a unique subset of T cells, in fighting these infections, showing strong antifungal properties against resistant strains by direct interaction with fungal hyphae.* -
  • The study highlights the promising role of Vγ9Vδ2 T cells as a new therapy for treating IA and mucormycosis, which could offer an effective alternative to traditional antifungal treatments that often have harmful side effects.*
View Article and Find Full Text PDF

Mucormycosis is receiving much more attention because of its high morbidity and extremely high mortality rate in immunosuppressed populations. In this study, we isolated a Cunnignhamella bertholletiae Z2 strain from a skin lesion of a 14 year, 9 months old girl with acute lymphoblastic leukemia who die of infection from the Z2 strain. Genome sequencing was performed after isolation and amplification of the Z2 strain to reveal potential virulence factors and pathogenic mechanisms.

View Article and Find Full Text PDF
Article Synopsis
  • Mucormycosis is a rare and serious fungal infection that is hard to diagnose early due to lengthy and complex testing methods.
  • A new rapid diagnostic method using Loop-mediated Isothermal Amplification (LAMP) has been developed, which is highly sensitive and doesn't require complicated equipment.
  • The study introduces a magnetic nanoparticle-based LAMP assay that targets a specific gene related to Mucorales, demonstrating quick detection of the infection in under 45 minutes using blood and urine samples from patients.
View Article and Find Full Text PDF

Want AI Summaries of new PubMed Abstracts delivered to your In-box?

Enter search terms and have AI summaries delivered each week - change queries or unsubscribe any time!